In world of stem cell research, ‘UC Caucus’ reigns supreme
By David Jensen,
Capitol Weekly
| 06. 21. 2021
They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years.
Not to mention that their employer — the University of California — is likely to snag much, much more during the next decade or so.
The “caucus” is composed of the 13 persons with ties to the University of California (UC) who are also members of the governing board of the state’s $12 billion stem cell agency, known officially as the California Institute for Regenerative Medicine(CIRM).
The board is so large, in fact, that at times its board members have outnumbered the CIRM staff.
The UC 13 constitute the largest voting bloc on the CIRM governing board. The “caucus” includes Art Torres, who is a member of the UC Board of Regents and the salaried, vice chairman of the CIRM board of directors. Torres is a well-seasoned, former state politician with decades of vote-counting experience.
The CIRM...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...